Cannalysis
PrivateLast Round
Series A
Sep 18, 2019
Total Funding Raised
$23.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cannalysis is a biotechnology and laboratory services company that provides state-licensed cannabis and hemp testing services using automated robotics and validated scientific methods.
Sector
Healthcare & Life Sciences
Verticals
Compliance, Quality Management, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cannalysis Comparables
Compare Cannalysis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BelCosta Labs Long Beach, LLC | 93% | |
| Infinite Chemical Analysis Labs | 93% | |
| CW Analytical Laboratories | 93% |
For institutional investors. Book with your work email.
Cannalysis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2019 | ||||
| Seed | Nov 8, 2017 |
For institutional investors. Book with your work email.
Cannalysis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Casa Verde Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 2004% MoM, from 361 to 7.6K.
- Jun 18, 2026
Monthly visitors grew 241% MoM, reaching 617.
For institutional investors. Book with your work email.
Cannalysis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cannalysis's valuation, stock price, and market status.
Is Cannalysis a public or private company?
Cannalysis is a private company.
What is the current stock price of Cannalysis?
Cannalysis is a private company, so its shares have no public market price. Caplight tracks Cannalysis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cannalysis worth (valuation)?
Valuation information for Cannalysis is not publicly available.
Can I buy Cannalysis stock?
Cannalysis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cannalysis's last funding round?
Cannalysis's most recent funding round was Series A on September 18, 2019.
Who are the main investors in Cannalysis?
Key investors in Cannalysis include Casa Verde Capital.
Will Cannalysis IPO soon?
No public IPO plans have been announced for Cannalysis.
How can I track Cannalysis secondary market activity?
Caplight tracks bids, offers, and trades in Cannalysis's shares on secondary markets.